Though BCR-ABLp210 can direct the lineage fate of HSCs, the presence of the BCR-ABLp210 protein alone may not be sufficient to initiate the chronic phase of human CML. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.